- ►ahajournals.org N Marx, J Wohrle, T Nusser, D Walcher, A Rinker, V … - Circulation, 2005 - Am Heart Assoc Methods and Results— Fifty nondiabetic patients after coronary stent implantation were randomly
assigned to pioglitazone (30 mg daily; pio) or placebo (control) treatment in addition to standard
therapy, and neointima volume was assessed by intravascular ultrasound at the 6-month ... Cited by 121 - Related articles - All 8 versions
- ►ahajournals.org JD Brown, J Plutzky - Circulation, 2007 - Am Heart Assoc Peroxisome proliferator–activated receptors (PPARs) are ligand-activated transcription factors
involved in the transcriptional regulation of key metabolic pathways such as lipid
metabolism, adipogenesis, and insulin sensitivity. More recent work implicates all 3 PPAR ... Cited by 105 - Related articles - All 8 versions
- ►sefap.it [PDF] DM Nathan - The New England journal of medicine, 2007 - nejm.highwire.org Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from
cardiovascular causes. N Engl J Med 2007;356:2457-71. Psaty BM, Furberg CD. Rosiglitazone
and cardiovascular risk. N Engl J Med 2007;356:2522-4. GlaxoSmithKline. Study no. ... Cited by 74 - Related articles - BL Direct - All 12 versions
K Nishio, M Sakurai, T Kusuyama, M Shigemitsu, T … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—A total of 28 patients were randomly assigned to the control group, and 26 patients
were assigned to the pioglitazone group. There were no significant differences in glycemic control
levels or in lipid levels in the two groups at baseline or at follow-up. Insulin, homeostasis ... Cited by 60 - Related articles - BL Direct - All 6 versions
P Libby, J Plutzky - The American Journal of Cardiology, 2007 - Elsevier Patients with type 2 diabetes mellitus and/or the metabolic syndrome have considerable cardiovascular
risk. Treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) and
with antihypertensive and some antihyperglycemic agents reduces this risk, but residual ... Cited by 60 - Related articles - All 32 versions
- ►nih.gov F Gizard, C Amant, O Barbier, S Bellosta, R … - Journal of Clinical …, 2005 - Am Soc Clin Investig Vascular SMC proliferation is a crucial event in occlusive cardiovascular diseases. PPARα is
a nuclear receptor controlling lipid metabolism and inflammation, but its role in the regulation
of SMC growth remains to be established. Here, we show that PPARα controls SMC cell- ... Cited by 59 - Related articles - BL Direct - All 10 versions
B Staels - Current Medical Research and Opinion®, 2005 - informahealthcare.com Département d'Athérosclérose – U.545 Inserm, Institut Pasteur de Lille, et Université de
Lille2, Lille, France ... Address for correspondence: Bart Staels, Département d'Athérosclérose
– U.545 Inserm, Institut Pasteur de Lille, 1 Rue Calmette BP245, 59019 Lille cedex, ... Cited by 55 - Related articles - All 6 versions
P Gervois, JC Fruchart, B Staels - Nature Clinical Practice Endocrinology & …, 2007 - nature.com Philippe Gervois is Professor of Biochemistry and Molecular Biology at the Université de Lille
2; he is also a Research Director at INSERM U 545, Institut Pasteur de Lille, Université de Lille
2, Lille, France. His research interests are focused on the elucidation of the mechanisms ... Cited by 53 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We examined a sample representative of the population
of Bruneck, Italy (n = 919; aged 40–79 years). Insulin-resistant subjects were those with a score
in the top quartile of the homeostasis model assessment (HOMA) for insulin resistance ( ... Cited by 47 - Related articles - BL Direct - All 5 versions
